IR LIBRARY News & Press Releases 08/28 Media Effects of emixustat hydrochloride in patients with proliferative diabetic retinopathy: a randomized, placebo-controlled phase 2 study 08/24 PR Kubota Vision Completes POC Clinical Study Using Wearable Myopia Control Device Based on Kubota Glasses Technology 08/20 PR Kubota Vision Receives Orphan Products Clinical Trials Grants to Emixustat for Stargardt Disease 08/20 PR Kubota Vision Announces Clinical Study Agreement with Insel Gruppe AG for PBOS more info For information on SEC filings, please visit U.S. SEC's EDGAR service. CEO Message Corporate Governance SEC Filings Shareholders Meeting IR Presentations Financial Events Calendar FAQs Email Alerts
